ORA BIO

Founded in 2005 Ora Bio Ltd, a biopharmaceutical company, is engaged in the repositioning of existing drugs for second-use applications.

The Company is developing its two products, the ORA101 and ORA102, as drugs for non-small cell lung cancer (NSCLC) and age-related macular degeneration (AMD) respectively. Both the company’s products are currently in Phase II clinical trials.


	Founded in 2005 Ora Bio Ltd, a biopharmaceutical company, is engaged in the repositioning of existing drugs for second-use applications. The Company is developing its two products, the ORA101 and ORA102, as drugs for non-small cell lung cancer (NSCLC) and age-related macular degeneration (AMD) respectively. Both the company’s products are currently in Phase II clinical trials.
Tel: +972-4-6564118 / +972-52-4811176 Fax: +972-4-6564129 Email: info@orabio.com P.O.B. 1252 Nazareth Illit 17000 Israel